Phase 3 Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Babies (boys or girls) who have a birth-related injury affecting the nerves in one arm or shoulder (on one side only)
- Babies who are between 10 and 11 months old
- Babies who show at least one of two specific warning signs that the shoulder joint may be at risk of slipping out of position: either the affected shoulder cannot rotate outward as far as the unaffected shoulder (by at least 10 degrees), or the baby scores below a certain level on a movement assessment that looks at how well they can rotate the shoulder outward, lift the arm, bend the elbow, or turn the forearm
- A parent or legal guardian who is 18 years or older has signed the consent form agreeing to their child's participation
Who may not be able to join:
- Babies whose nerve injury affects both arms or shoulders
- Babies for whom specialised nerve or muscle surgery is already planned between 12 and 18 months of age
- Babies for whom botulinum toxin (a medication used in the trial) would not be considered safe to use
- Babies for whom an MRI scan would not be safe
- Babies for whom an MRI scan cannot be carried out in a paediatric day hospital setting, either due to safety concerns related to the sedation (light anaesthetic) required or due to practical limitations at the site
- Babies whose parents or guardians are not in a position to give consent for their child to participate
- Babies whose parents or guardians are under 18 years of age
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (+33) 02 98 22.33.73
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in the percentage posterior migration of the humeral head measured on axial MRI slices between 11 (before the BTI carried out at 12 months) and 18 months of age (6 months post BTI).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.